Researchers from the Brain Imaging Center at McLean Hospital and Repligen
Corporation reported today the results of a clinical trial designed to assess
the neurological activity of secretin by functional magnetic resonance imaging (fMRI).
The results demonstrate for the first time in humans, that secretin is active in
the central nervous system and that it potentiates activity in the amygdala, a
region of the brain involved in social integration and implicated in autism. The
findings were presented today by Deborah Yurgelun-Todd, Ph.D., of McLean
Hospital, the study's Principal Investigator, at the International Meeting for
Autism Research (IMFAR), a satellite meeting of the Society for Neuroscience.
"Our results demonstrate for the first time that secretin is a neuroactive
peptide in humans and that it acts on a brain region known to be important for
social interaction," stated Yurgelun-Todd, Director of Cognitive Neuroimaging at
the Brain Imaging Center at McLean Hospital. "These findings suggest that
secretin may have a role in modulating certain social behavior in humans."
The study was a double-blind, placebo-controlled clinical trial in 12 healthy
men. Each subject was presented with a series of pictures of faces with either a
neutral, happy or fearful facial expression to establish a baseline response.
Following an injection of either secretin or a placebo, the subjects were again
presented with the series of facial expressions. Throughout the experiment, the
activation of the amygdala was recorded with MRI. There was a significant
activation (p=0.001) of the right amygdala by secretin when the subjects viewed
pictures of a fearful face compared to both the placebo group and the baseline
response to the pictures in the secretin group.
By contrast, there was no difference in amygdala activation when subjects
viewed pictures of neutral or happy faces. Failure to activate the amygdala when
viewing fearful faces is a characteristic of people with autism and patients
with amygdala damage. The current study was initiated as part of ongoing
research efforts to understand secretin as a neurologically active peptide.
Repligen previously reported a finding that treatment of rats with secretin
specifically activates the neurons in the amygdala. Repligen is currently
developing secretin for autism in a Phase 3 clinical trial program.
"These studies show that secretin is active in a part of the human brain
involved in social interaction and potentiates its activity during a social task
known to be difficult for people with autism," stated Walter C. Herlihy, Ph.D.,
President and Chief Executive Officer of Repligen Corporation. "These data
provides a plausible biological mechanism for the improvements in social
interaction we observed in our Phase 2 clinical trial."
The Amygdala and the Social Deficits of Autism
The amygdala is part of a complex neural system that is critical for
ascribing emotional value to stimuli and influencing affective responsiveness
and emotional learning. One of the core deficits of autism is impaired
reciprocal social interaction, including eye contact, joint attention and an
inability to deduce the mental states of others from facial expressions. Reduced
activation of the amygdala in patients with autism has been documented using
fMRI with specific impairment noted in their ability to respond to facial
expressions of fear. Other studies indicate that patients with either surgical
or congenital amygdala damage show similar face recognition defects. Lack of
activation of the amygdala is recognized as an important correlate of the social
deficits of autism.
Repligen's President and CEO Walter C. Herlihy, Ph.D. also presented data
from its Phase 2 clinical trial. The Phase 2 study evaluated three
administrations of secretin or a placebo in 126 patients aged 3 years to 6 years
11 months with moderate to severe symptoms of autism and gastrointestinal
disorders. The primary finding of the Phase 2 clinical trial was that younger
children, 3 and 4 year olds, showed improvements in reciprocal social
interaction as judged by a standardized clinical instrument for the assessment
of autistic symptoms. Repligen is currently conducting a Phase 3 clinical trial
of secretin for the improvement of reciprocal social interaction in young
children with autism.
Within a year, researchers will probably identify the first "strong candidate
genes" that make children vulnerable to autism, Joseph Daniel Buxbaum, who heads
the neuropsychiatric lab at Mount Sinai Hospital in New York, said yesterday.
Buxbaum, who has spent five years searching for the genes, said that
laboratories working on the genetic roots of autism have made surprising
progress over the past year. Autism is a brain disorder that leaves children
unable to communicate or form normal relationships.
"I go through periods of optimism and pessimism, and I've been optimistic for
a good long time now," said Buxbaum, who spoke at a conference on the disorder
sponsored by LADDERS, a neurological clinic affiliated with the Massachusetts
General Hospital.
But he warned that families should not assume that the discovery of the first
genes will translate into treatment or prevention over the short term or even
within their children's lives.
"It's the first thread," said Buxbaum, an assistant professor of psychiatry
at the Mount Sinai School of Medicine. "Families want to know when the ball of
yarn is going to unravel. Scientists want to know when it is going to start to
unravel." The hunt for the autism gene, begun with great optimism in the
mid-1990s, has proven far more difficult than expected, and many parents and
advocates contend that it is caused by environmental factors such as vaccines or
infections.
Diagnoses of autism - an inability to communicate and form relationships -
are increasing nationwide, radically in some locations, although some scientists
believe that better diagnosis may account for the sharp rise. A study
commissioned by the California Legislature reported last month that autism had
increased by 273 percent between 1987 and 1998.
Few brain disorders have been more perplexing than autism, which strikes at
the age of 18 months to 3 years and leaves children isolated from the world
around them.
Researchers studying twins have found that many, but not all, identical twins
share the disorder, suggesting that genetic factors are important, but that
environmental factors can make a child more vulnerable.
Meanwhile, lawsuits have proliferated as parents identified environmental
causes for their children's illness, most commonly, a childhood measles vaccine
that contains minute traces of a mercury preservative.
US Representative Dan Burton, Republican of Indiana, whose grandson has
autism, urged a congressional inquiry into what he terms an epidemic.
Two years ago, researcher Buxbaum's hope to find the cause and a treatment
for autism had reached a low ebb, even as advocacy for the disease grew
stronger. Emerging from a successful quest for the genetic roots of Alzheimer's
disease, he had expected to isolate three or four genes linked to autism in the
course of a year or so. It didn't happen.
"It seemed like we weren't going to get it," he said. "I was telling people
to stay in the business just so that we would have a holding pattern." But the
last year has brought increased collaboration between international research
teams, increased funding, and better technology. By dividing sample sets
according to special characteristics, researchers have found much stronger links
between regions of the human genome and the illness. Once the first genes are
identified, Buxbaum said, later genes should be identified with less time and
effort.
Scientists from Tufts-New England Medical Center and Massachusetts General
Hospital warned against attaching too much hope to the the research. Unlike
sickle-cell disease or Tay-Sachs disease, autism has such complex causes that
there is little likelihood of a simple prenatal screening test for the disease.
Even if researchers succeed in identifying genes that make children
susceptible to autism, it is unclear whether the discovery would lead to the
development of new therapies in the near future, Buxbaum said.
Susan Santangelo of the Psychiatric and Neurodevelopmental Unit at MGH said,
"If we find something that directly positive, we'll be extremely lucky." But if
it turns out that the genes launch a process that begins very early in a child's
development and affects an area deep inside the brain, then the prospect of
developing a preventive therapy may seem more distant than ever, she said.
First among those to whom Peter Hobson's book is dedicated is his long-time
colleague Beate Hermelin, who is well known for her pioneering work on the
talents of autistic savants. Last year Hermelin's wonderful personal story of
her research was published (Lancet 2001; 358: 515). In many ways, The Cradle of
Thought is also a personal account of Hobson's experiences as a researcher and
clinician.
Both books grapple with the mystery of autism, but lead to different
conclusions. Hermelin highlights the contrast in cognitive style between
ordinary people (who get the gist of things but often miss details) and autistic
savants (who use details as a base for extracting patterns and structures,
visually, musically, or numerically). Hobson, by contrast, locates the
difference as between, rather than within, people. Very simply put, Hobson's
view is that "triangles of relatedness" provide infants with alternative
perspectives on the world that when integrated form the foundations for symbolic
thinking. Children with autism lack an innate emotional sense of other people
being like themselves, and so fail to integrate other people's perspectives with
their own, which leads to deficits in pretend play and other symbolic
activities.
Unlike Hermelin, who gives an incisive account of a specific phenomenon,
Hobson addresses a panoply of topics, moving from research on normal
developments in infancy and toddlerhood, to the disturbed interactions of
mothers with borderline personality disorder and their infants, to research on
why children with autism lack a "theory of mind" (the ability to attribute
mental states to self and others). This range of issues is the book's strength
and weakness. The reader is caught up in a whirlwind tour of research findings
and clinical insights, which makes the book a genuine page-turner, but is left
with a feeling of unease because of the vagueness of some of Hobson's proposals
and a few curious omissions.
For example, exactly what kind of "thought" is Hobson talking about? In the
preface, he refers to Wittgenstein's philosophical account of how people
understand minds as being a seminal influence on his work. It is noteworthy that
Wittgenstein is thought by some clinicians to have displayed features of
Asperger's syndrome, but was, nevertheless, a great thinker. Hobson's view of
how mental life is affected by autism is perhaps too global, and runs against a
recent shift towards viewing cognition in autism as being different rather than
deficient.
Although Hobson does not believe that autism results from bad parenting, he
fails to mention that psychoanalysts have, in the past, claimed just that. Given
the damage to relations between parents and professionals after the publication
of Bettelheim's thesis in 1967, which claimed that autism was caused by
"refrigerator mothers", we have good reason to treat psychoanalytic views of
autism with caution. Unfortunately, Hobson does not spell out just how his
account of autism differs from previous psychoanalytic interpretations.
Although autism is an enigmatic disorder, careful experimental research has
led to advances in our understanding. This progress is the result of
experimental studies that require testable hypotheses--a method that allows
ideas to be reformulated if necessary. This is not to say that observations and
case studies are not inspirational (they are, and are useful for sifting out
implausible accounts). Neither is it to deny the importance of taking emotional
understanding and relationships seriously--both factors have been neglected by
researchers. But, if, as Hermelin suggests, autism involves a qualitatively
different mode of thought, then Hobson's leaps between research findings on
normative individual variation and on autism may be dangerous. Finally,
theory-of-mind research carries a lesson for psychoanalysts who, by focusing so
hard on the mother-child relationship, risk missing all the action (and emotion)
that occurs between siblings, peers, and friends. So yes, relationships matter,
but in more ways than one.
The Anna Sullivan Centre in Lima uses PECS to help people with autism and
learning difficulties.
Teachers urge students to communicate through pictures. For instance, if a
child wants a drink they will present a picture of a drink.
After a while, they are able to construct simple sentences using pictures.
They are then taught to associate the pictures with words and many go on to
speak.
The centre's founder, Liliana Mayo, says PECS has helped many people to learn
to communicate.
"This system has offered them the possibility of expressing what they want,
how they need, how they feel, even if they are happy. But if they feel pain
too," she said.
The programme has made a big difference in many people's lives.
"It has made a big difference because many children used to have a lot of
behavioural problems - crying, screaming and hitting," she said.
"Once they start to show us with the pictures what they want, their life
changes not only for the child but for the family.
Overcoming problems
"Families often say I didn't understand what they wanted to ask me."
She added: "The most important aspect of any human being is their voice and
PECS is like the voice for the children.
"When kids didn't know how to talk they were very frustrated that they could
not communicate."
Around 350 students, all with varying degrees of learning disability, attend
the centre each day.
Many could not speak or communicate in any meaningful way before they
started.
Milagros Rodrigues said she had seen dramatic changes in her daughter
Camilla.
"Before using PECS Camilla was able to repeat words in Spanish, but she
didn't understand them," she said.
"The traditional system of language therapy was not successful with her. She
could repeat words, she was able to repeat the word mesa or table but when I
told her go to the mesa, she didn't know the meaning of mesa."
For Camilla, Spanish was like a second language, even though it is her mother
tongue.
Now, armed with a scrap-book full of pictures and a sticky ruler on which to
pin the appropriate image, she can tell the difference between, say, a sandwich
and an orange.
Most importantly, she can now tell other people which one she would rather
eat.
Successful as PECS has been, it is not appropriate for all people with
autism. Those that can already talk, for example, do not need it.
Great progress
Similarly, it is not just children with autism that benefit from PECS. Elsa
Dawson, a Briton living in Peru, comes to the centre with her seven-year old
daughter Elisa who has Angelman syndrome.
Her symptoms include communication difficulties, imbalance and a short
attention span. Elsa had tried using PECS before, but with little success.
"We've only been at the Anne Sullivan for two or three months with Elisa, but
the progress that she's shown is really incredible," said Elsa.
"She's learning to dress herself, she's learning to communicate through the
PECS system, she's learning to use the toilet, how to sit quietly in the
classroom.
"And although she's not really very happy, we think she's enjoying the fact
that she's learning these skills, which unfortunately she wasn't learning at the
special schools she was at in England."
This story is featured in the radio programme Health Matters on the BBC World
Service.
* * *
Hope for a Son's Rise
Daring to seek a cure, parents try an untested program
Julian Nazar spends his school days in an attic playroom showing the
volunteers what to do. They paint, discuss dragons and bounce on a trampoline --
the adults taking their cues from the animated, autistic 5-year-old while his
parents watch through a one-way mirror.
It is an intense effort to prepare Julian for public school next year. It is
also risky -- inviting unskilled volunteers to teach a child who finds it
difficult to cope with change and social situations.
The unusual program, called Son-Rise, is based on the notion that working
closely and intensively with autistic children can make them better. No data,
however, support it. It's expensive and time-consuming. And only about 30 North
Carolina families have tried it since the program started at a for-profit
training institute more than 25 years ago.
But Son-Rise offers the Nazars what no one else would: a possible cure.
Behavioral therapists don't. Neither does the nationally recognized TEACCH
program at UNC-Chapel Hill, which many local public schools follow. They treat
autism as a lifelong disability families can learn to live with.
Doctors discovered Julian had a mild form of autism two years ago. His
parents realized they mistook symptoms -- withdrawal, tantrums, repetitive
speech -- for jealousy because his mother was pregnant and getting more
attention.
Julie Nazar, 44, recalls the diagnosis as "very tragic" for her and her
husband.
"It felt like a death sentence," she said. "It was a grieving process. ...
You go through all those stages: denial, why me? There were many times we'd just
break down sobbing, both of us.
"It didn't give any hope."
Neither did most of what they read about autism. Books told them Julian's
brain was wired differently from most kindergartners'. He could not hold a
pencil well enough to draw. He saw the world as a mass of confusing images and
noises. He was fine alone, but when a couple of children came over or when he
went to the grocery store, he threw monster tantrums. "Meltdowns," the Nazars
called them.
Or else, his parents said, Julian silently retreated, trancelike, into "his
world." It is a place where he hits his head against the wall repeatedly and
says he likes it, where creativity is difficult, eye contact more so.
Ask Julian to pretend to be a panda bear, he says no. Name a zoo animal and
he demands the name of another, and another. Set up a plastic castle and he
wants every piece to remain in place for weeks.
He looked like the normal pre-schooler his parents wished him to be, with
wide chocolate-brown eyes and a quick, impish grin.
Autism affects about one in 500 children, a total of 1.5 million people
nationwide, with the number diagnosed rising more than 10 percent each year.
Boys are four times more likely to be diagnosed. Children can suffer mild
symptoms like Julian's or, in more severe cases, mental retardation.
Last year, Wake County schools saw 401 autistic students enroll, nearly twice
the number in Charlotte-Mecklenburg, the state's largest school system. One
reason is that there are more resources in the Triangle, and families dealing
with autism are drawn to the area.
Many moved to the Triangle to be closer to TEACCH, the UNC program that
trains teachers, parents and psychologists to use visual aids and other tools to
help autistic children in the classroom.
Child psychologists at TEACCH advised the Nazars that Julian would always be
a bit eccentric. Marcus Nazar pictured his son learning to follow social
conventions the way other children learn to play piano.
Lee Marcus, clinical director of the TEACCH center, says he never tells
families that autism can be cured.
"We just assume that if this person has this, autism, it's a part of their
life," he said. "They can make gains, they can get jobs and live lives that are
fine, but we don't talk in terms of normalcy any more than we would if someone
had cerebral palsy."
Calling in the village
Since TEACCH had a year-long waiting list, the Nazars had time to consider
options. Julian started kindergarten, and they tried their own brand of
behavioral therapy. When Marcus Nazar caught his son repeating a phrase
interminably -- "My name is Julian, I'm a boy" -- he firmly told him to stop,
and Julian complied after a few more repetitions.
But moments later, his father despaired when he found his son crouched behind
a sofa, repeating the phrase quietly to himself.
The Nazars wanted Julian to really change, not just mimic normal behavior.
They read about Son-Rise, which told them to follow Julian's lead until he
wanted to stop. They tried that approach. After a week, Marcus Nazar said,
Julian stopped repeating the phrase. "And it was not artificial," he said.
Instead of registering Julian for school, the Nazars decided to try the
program full time. In June, they built the isolated playroom described in
Son-Rise books. Julie Nazar quit her job as an English as a Second Language
teacher at Wake Technical Community College to stay home with her son.
But she and her husband, a 44-year-old computer programmer, realized they
would need help. Julian would have to stay in the playroom at least six hours a
day. So they did what other parents in the program have -- they sought
volunteers, asking friends and posting fliers at grocery stores and the Cary
Public Library.
By August, the couple had selected about 10 helpers, and they are eager to
add to the group. It includes a computer programmer, a physician's assistant, a
stay-at-home mom and a retired couple. Most are acquaintances, but some are
strangers who wanted to help.
"This program really allows friends and family and community an opportunity
to really grow," said volunteer Susan E. Humphries, 29, of Raleigh, a state
Medicaid program supervisor. "It gives you a very unique space and place to
really get in touch with people who have challenges."
The first time each of the unpaid volunteers works with Julian, they come
prepared. The Nazars lend them a BBC documentary video about the program and
some books written by program founder Barry Kaufman, including
"Son-Rise: The Miracle Continues," which chronicles the success of his
autistic son, now an Ivy League graduate.
Julian leads them into his playroom, about the size of a spacious walk-in
closet. A padded cream-colored linoleum floor muffles distracting sounds. High
shelves and nearly bare walls minimize distracting sights. For the next two
hours, they follow his lead.
"This is the nature of the program," Marcus Nazar said. "Follow him into his
world, and he has to follow us back into ours -- if he chooses."
One of the Nazars silently observes through the one-way mirror and afterward,
the adults huddle to analyze what was accomplished. Did Julian look them in the
eye when they read him a story or talked about their dog? Did he share his toys?
Volunteers said they often wonder if they let the boy go too far.
"I got worried about him slamming into the mirror," volunteer Karen L.
Ziegler, 49, a nurse from Durham, wrote earlier this month.
"His experience makes me want to explore further what it is that causes
Julian to take an activity to its extreme until it becomes out-of-hand," helper
Bernice Harvey, 73, a retiree from Lillington wrote last month after Julian
started coating himself with black crayon.
Despite such behavior, the Nazars and their volunteers say Julian has made
rapid progress. So do the daily reports, which describe him making regular eye
contact, inventing stories about a boy in Africa and drawing a picture of
himself covered in marshmallows.
Untested, untrusted
The program's critics say such measures of success are too subjective.
Son-Rise has not been independently studied. Kaufman says such studies include
control groups that are refused treatment, and he is not in the business of
turning people away.
Son-Rise is a business, which poses another problem, critics say: the
significant up-front investment of time and money.
The Nazars spent several thousand dollars to renovate the playroom and send
Julie Nazar to Son-Rise headquarters in Sheffield, Mass., for training.
The Nazars are trying to raise money to attend a month-long session in
Sheffield with Julian in May. The cost: $10,000, not including $200 for
follow-up phone consultations.
Dr. David Holmes is among skeptics who doubt the program will live up to the
Nazars' hopes. He is director of the Eden Institute for autistic children and
adults in Princeton, N.J., and chairs a panel of professional advisers to the
Autism Society of America, an organization of 20,000 families and professionals
in all 50 states.
Holmes isn't surprised that some parents, even in "the back yard of TEACCH"
will try anything to cure their child.
"We can't cure autism because, first of all, it's not a disease. It's a
syndrome, and there could be many causes," Holmes said.
Could an autistic child blend with his peers?
"There have been cases," Holmes said, like Kaufman's son.
But did the boy really overcome autism, Holmes wondered, or simply learn to
live with it?
The Nazars want a son who can enjoy a soccer game with friends or play with
his 16-month-old brother, Benjamin. Years ago, they donned clown wigs and face
paint to entertain at children's parties. They show volunteers pictures,
including a later shot of Julian in clown gear, and say they can't imagine him
unable to feel life's twin rushes of joy and pain.
Some volunteers tell them they think Julian will be ready to attend public
school next fall. Others say it could take longer. He reverts to old behaviors
when he leaves the playroom, they point out, but is making great strides inside.
They all agree a cure is possible, despite what the experts say.
"They say it's not fair to give these people hope," said volunteer Willis B.
Harvey, 76, a retired real estate developer. "Goodness, you lose hope, and
there's nothing there for you."
* * *
CARE
Group Offers Support To Cope With Asperger's
Deirdre Wright of Havertown formed Ascend to deal with Asperger's syndrome.
[Deirdre Wright writes in to share this article. "Here's a link to the Sunday
Philadelphia Inquirers People in the News column with a feature about yours
truly. One of the members of my support group recommended me for a profile. I am
so flattered! And I love having another opportunity to raise awareness about
Asperger Syndrome. There are some factual errors in the article, most glaringly
in the headline: 'Group offers support to cope with a childhood illness.' I wish
the reporter would have done some better research. " We changed the headline,
but not for the reason you cited. There is indeed a growing number of autism
observers who believe there is an illness underlying autism. LS By Wendy Walker
in the Inquirer Suburban.]
After her son Graham was diagnosed with an uncommon neurological disorder
called Asperger's syndrome, Havertown resident Deirdre Wright put her
public-relations skills to work.
She started a group called Ascend Group Inc. that serves as a resource for
parents of children with Asperger's and related disorders.
"When some people hear the words 'support group,' they think it's people
sitting in a circle, crying," said Wright, the group's president. "That's not
what it's about."
The goal of Ascend is to fight the isolation of parents who think "we must be
the only people with this odd diagnosis," she said. "By getting together, we can
share information about schooling and diagnosis and treatment."
Barb Kaplan, also of Havertown, is a member of the group. She has found help
from Ascend, and she said of Wright: "She is a dynamic lady who saw a need and
filled it. Marvelous!"
The group, which meets at the Grace Chapel at Darby and Eagle Roads in
Havertown, has two types of meetings held in alternate months: discussions, and
sessions with guest speakers. The group also has created a directory of members
and resources, professionals who are familiar with Asperger's and other
neurological disorders.
Ascend's first meeting, in April 2001, drew 50 people, after Wright sent out
flyers and contacted Intermediate Unit personnel. It has since become a
registered nonprofit agency, with a membership fee of $20 and a Web site (
www.ascendgroup.org).
The group's official name is the Asperger Syndrome Information Alliance for
Southeastern Pennsylvania.
"We now have more than 150 member families and a dozen professional members
from throughout the five-county region," said Wright, who receives several calls
(610-449-6776) and e-mails (dcwright@ascendgroup.org) each week from parents and
professionals.
Asperger's syndrome, named after the Viennese pediatrician who identified it
in 1944, is a disorder similar to autism, but children with Asperger's can
function better.
"The main problem is with social interaction," Wright said.
Because Asperger's children have trouble interpreting social and nonverbal
cues, they can become easily confused and left out of conversations.
"You start out thinking your child is just shy, and then eventually you
realize it's more serious," Wright said. Her son, now 7, was diagnosed at age 5,
while she was pregnant with her daughter Ruby.
Graham was having temper tantrums "because he couldn't sort out what was
going on in the world."
Her reaction to the diagnosis was typical, she said: "I'd never heard of it.
I felt alone and depressed."
It was another year until Wright, who grew up in Cortland, N.Y., met another
parent and got the group started.
Various forms of treatment can be helpful, she said, such as social-skills
groups and therapy with a psychologist or behavior specialist.
Running the group takes a lot of her time, said Wright, who does freelance
business writing. "It's a sacrifice I'm willing to make," she said. "Sure, if I
were writing about the latest hand sanitizer or something, we as a family could
have more stuff, but the time I'm investing in building a community is just so
important right now."
As reported previously, the Superior Court in San Diego found, at a September
6, 2002 hearing, that Karen DeFelice's lawsuit against ARI, Bernard Rimland, and
ARI DAN! Conference coordinator, Maureen McDonnell, was without merit, and that
Karen DeFelice must pay the attorneys' fees and costs incurred by ARI, Rimland
and McDonnell.
On November 1, 2002 the court held a second hearing, to determine the amount
Karen DeFelice is required to pay to reimburse ARI, Rimland and McDonnell for
their expenses in defending against Karen DeFelice's lawsuit. The official court
order states: After reviewing the moving and opposing papers, and hearing the
arguments of counsel, the Court rendered its decisions on September 6, 2002 and
November 1, 2002. Those Minute Orders are incorporated by this reference.
Therefore, It Is Adjudged, Ordered And Decreed As Follows:
1. Plaintiff shall take nothing by her complaint;
2. Autism Research Institute and Bernard Rimland shall have and recover from
plaintiff the amount of $22,334.00; and 3. Maureen McDonnell shall have and
recover from plaintiff the amount of $17,460.00.
- Hon. Patricia Yim Cowett
Judge Of The Superior Court
Comment from Bernard Rimland, "While it was very clear from the outset that
Ms. DeFelice had no possibility of winning her lawsuit against us, we were
nevertheless compelled to defend ourselves. The $40,000 in reimbursement for
legal costs, which Ms. DeFelice must now pay, does not begin to compensate for
the enormously larger cost in time and attention that the lawsuit has diverted
from our mission--the defeat of autism."
[Brief commentary: Karen DeFelice has a natural compassion for helping
families and children explore potential benefits from their experimental use of
digestive enzymes as treatments for the gastrointestinal and behavioral symptoms
of autism. For her work there, she has won the loyalty of some parents who have
seen improvements in the health of their children as a result of her counseling
and the enzymes she promotes.
Unfortunately DeFelice also has a passion for bilious public attacking and
threatening of her critics. DeFelice threatened at least one other parent
advocacy group and an individual with legal action, but with Rimland and Company
she followed through with her threat, hoping to intimidate the DAN! Conference
people to allow her into their midst, after they refused her application as a
vendor for supplements.
The autism community is indebted to Rimland and Company for holding firm and
limiting her further access to the autism community through their conferences.
Sad to say, whether $40,000 is enough to dissuade DeFelice from her
self-destructive tactics remains to be seen as she continues to stream invective
from her list group even today. What wondrous things could be accomplished would
all this energy and money be put to constructive use. It's never too late.
Lenny Schafer.]
* * *
AWARDS
Rimland Featured in Magazine, To Be Awarded at NVIC Conference
Bernard Rimland, founder of the ASA and the Autism Research Institute,
continues to get well-deserved accolades from the rational folks in our
community, who appreciate what he had accomplished in this forty-plus years
(some may say in his "forty-odd years") of tireless struggles on behalf of
autistic children and their families.
* The November-December, 2002 issue of Mothering Magazine features Bernard
Rimland as a "living treasure", with a nice photo and bio on page 88.
* The National Vaccine Information Center (NVIC) will present him with its
"Courage in Science Award", Saturday evening, November 9th at its third annual
Public Conference on Vaccination. The conference runs from November 7 to
November 10thin Arlington, VA. For conference information,
My son has autism. Are there any studies published about the rate of autism
rise in children around the world who HAVE NOT been vaccinated? I would be
interested in knowing the autism rate in that population. Or is it only a
coincidence that only children who have been vaccinated are the ones who wind up
with autism? Hazel hazeldorsey@hotmail.com
******
Grandmother with 5 year old autistic boy wants to know if anyone who has
tried Formula One (in preparation for MT Protein chelation) has seen an adverse
reaction in behavior to the extreme. Don't know if this is cause or minor virus
which caused reaction. Maurine emaurine@webtv.net
******
My 7 year old autistic son attends 1st Grade in a General Education classroom
without a Special Educator. My son is an excellent reader, but he has difficulty
with the comprehension questions in his reading group. I'm not sure if the
problem is him, or the way the questions are being presented. Does anyone have
suggestions, for me to pass to the teacher, on how to address the comprehension
questions? Douglas.Shade@baesystems.com
******
Neurologist said our autistic son tested positive for antibodies on the
frontal lobal part of the brain. He is 9 and very low functioning with
regression. He suggests steroids. What do you think? rosalind@erols.com
******
Seeking intelligent, responsible therapist to facilitate playdates
incorporating theory of mind, executive function, and central coherence concepts
in the Newport Beach, CA area. Hours flexible. lagunamurphy@cox.net
******
>> FREE (Almost) READERS' POSTS <<
For Individuals, organizations, non-commercial and
commercial. Limit your posting to no more than 60
words please. There is no charge for this service,
but posters are obligated to thank all those who take
the time to answer your ads. This is a consideration
for others with autism after you and yours, who seek
assistance from appreciated readers. Send submissions to:
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"